20
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Subsets of T-cells and In Vitro Cytokine Production After Measles and Varicellae-zoster Virus Antigen Stimulation in Allogeneic BMT Patients

Pages 43-49 | Published online: 08 Jul 2009

  • Aicardi J, Goutieres F, Arseni-Nunes ML. Acute measles encephalitis in children with immunosuppression. Pediatrics 1977; 59: 232–9.
  • Schimpf S, Serpick A, Stoler B, Rumack B, Mellin H, Joseph JM, Block J. Varicella-zoster infection in patients with cancer. Ann Intern Med 1972; 76: 241–54.
  • Meyers JD, Flournoy N, Thomas ED. Cell-mediated immunity to Varicella-Zoster virus after allogeneic marrow transplant. J Infect Dis 1980; 141: 479–87.
  • Ljungman P, Lonnqvist B, Gahrton G, Ringden O, Sundqvist VA, Wahren B. Clinical and subclinical reactivations of Varicella-Zoster virus in immunocompromised patients. J Infect Dis 1986; 153: 840–7.
  • Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA. Measles antibody: Reevaluation of protective titers. J Inf Dis 1990; 162: 1036–42.
  • Ruckdeschel JC, Graziano KD, Mardiney MR Jr. Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola). Cell Immunol 1975; 17: 11–8.7. Mosmann T. Properties and functions of interleukin 10. Adv. Immunol 1994; 56: 1–26.
  • Yssel H, de Waal Malefyt R, Roncarolo MG, Abrams JS, Lahesmaa R, Spitz H, deVries JE. IL-10 is produced by subsets of human CD4 + T-cell clones and peripheral blood T-cells. J Immunol 1992; 149: 2378–84.
  • Ringdén O, Pihlstedt P, Markling L, Achan J, Baryd I, Ljungman P, et al. Prevention of graft-versus-host disease with T-cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 1991; 7: 221–6.
  • Lönnerholm G, Carlsson K, Bratteby LE, Bäcklund L, Hagberg H, Rikner G, et al. Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 1991; 8: 129–34.
  • Ljungman P, Fridell E, Lönnqvist B, Bolme P, Böttiger M, Gahrton G, et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989; 159: 610–5.
  • Sundqvist VA. Frequency and specificity of varicellae zoster IgM response. J Virol Meth 1982; 5: 219–27.
  • Örvell C. Immunological properties of purified mumps virus glycoproteins. J General Virology. 1978; 41: 517–26.
  • Pauksen K, Linde A, Ljungman P, Bolme P, Lönnerholm G, Öberg G, et al. Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation. Bone Marrow Transplant 1995; 16: 807–13.
  • Ljungman P, Lonnqvist B, Wahren B, Ringdén O, Gahrton G. Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients – a one-year follow-up. Transplantation 1985; 40: 515–20.
  • Lenkei R, Andersson B. Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors. J Immunol Method 1995; 183: 267–77.
  • Ljungman P, Wahren B, Sundqvist VA. Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase. J Virol Methods 1985; 12: 199–208.
  • Pauksen K, Sjölin J, Linde A, Alm G, Andersson B, Lönnerholm G, et al. Th1 and Th2 cytokine responses after measles antigen stimulation in bone marrow transplanted patients: response to vaccination. Bone Marrow Transplantation 1997; 20: 317–23.
  • Jenkins DE, Redman RL, Laam EM, Liu C, Lin I, Arvin AM. Interleukin (IL)-10, IL-12, and Interferon -(production in primary and memory immune responses to Varicella-Zoster virus. J Infect Dis 1998; 179: 940–8.
  • Quinnan GV Jr, Kirmani N, Rook AH, Manischewitz JF, Jackson L, Moreschi G, et al. Cytotoxic T-cells in cytomegalovirus infection. HLA-resticted T-lymphocyte and non T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone marrow transplant recipients. N Engl J Med 1982; 307: 7–13.
  • van Binnendijk RS, Poelen MCM, deVries P, Voorma HO, Osterhaus ADME, Uytdehaag FGCM. Measles virus-specific human T-cell clones. Characterization of specificity and function of CD4 helper/cytotoxic and CD8 + cytotoxic T-cells. J Immunol 1989; 142: 2847–54.
  • Fowler DH, Breglio J, Nagel G, Eckhaus MA, Gress RE. Allospecific CD8 + Tc1 and Tc2 populations in graft-versus- leukemia effect and graft-versus-host disease. J Immunol 1996; 157: 4811–21.
  • Witherspoon RP, Matthews D, Storb R, Atkinson K, Cheever M, Deeg HJ, et al. Recovery of in vivo cellular immunity after human marrow grafting. Transplantation 1984; 37: 145–50.
  • Storek J, Witherspoon RP, Storb R. T-cell reconstitution after bone marrow transplantation into adult patients does not resemble T-cell development in early life. Bone Marrow Transplantation 1995; 16: 413–25.
  • Jin NR, Lum LG, Buren EV, Lerman SP, Walker AL, June CH. Signal transduction by Band T-cells early after bone marrow transplantation: B cell calcium flux response are intact whereas lack of CD4 cells account for impaired T-cell response. Bone Marrow Transplant 1995; 16: 103–9.
  • Storek J, Witherspoon RP, Storb R. T-cell reconstitution after bone marrow transplantation into adult patients does not resemble T-cell development in early life. Bone Marrow Transplant 1995; 16: 413–25.
  • Victor J, Knudsen JD, Nielsen LP, Formsgaard A, Thybo S, Bygbjerg I, et al. Hepatitis A vaccine. a new convenient single-dose schedule with booster when long-term immunization is warranted. Vaccine 1994; 12: 1327–9.
  • Pauksen K, Hammarström V, Ljungman P, Sjölin J, Öberg G, Lonnerholm G, et al. Immunity to polio virus and immunization with inactivated polio virus vaccine after bone marrow transplantation. Clin Inf Dis 1994; 18: 547–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.